Skip to main content
. Author manuscript; available in PMC: 2025 May 14.
Published in final edited form as: Nat Rev Neurol. 2024 Feb 29;20(4):245–251. doi: 10.1038/s41582-024-00940-4

Table 1 ∣.

Similarities and differences between sporadic and familial Alzheimer disease

Feature ADAD EOAD LOAD
Age at onset (years) <50 <65 ≥65
Sex distribution75 Female = male Female = male Female > male
Episodic memory loss Earlya Earlya Earlya
Atypical signs and signals4,76 Common Higher frequency of dysexecutive symptoms and atypical presentation than LOAD Uncommon
Genetic contributions Autosomal dominant Probably polygenic Probably polygenic
Frequency of APOE4 carriers (%)28,77-80 Up to 30 ~60 (except for low frequency in atypical cases) ~60
Neuropathological hallmarks Plaques and tangles Plaques and tangles Plaques and tangles
Structure of amyloid-β filaments30 Type II Unreported Type I
Pattern of amyloid-β spread81,82 Neocortex first; 10–20% with striatal origin Neocortex first Neocortex first
Presence of plaque variations in addition to the common neuritic and diffuse plaques83,84 Cotton-wood type Subset of cases with coarse plaques Rare cases with coarse plaques
Initial tau accumulationb (refs. 85,86) Unknown Subcortical nuclei belonging to the neuromodulatory subcortical systemc Subcortical nuclei belonging to the neuromodulatory subcortical systemc
First regional evidence of PET signald (refs. 87,88) Precuneus Mesial temporal region Mesial temporal region
Tau burden31,89,90 Higher in the striatum than in sporadic cases Higher in cortical areas than in LOAD Higher in limbic areas than in ADAD and EOAD
Rate of brain atrophy81 Fast Fast Slow
Highest magnitude of brain atrophy91-93 Neocortical and medial temporal Neocortical > medial temporal Medial temporal > neocortical
CSF assays of amyloid-β42; amyloid-β40; tau; phosphorylated tau181 (ref. 81) Reduced; reduced; increased; increased Reduced; reduced; increased; increased Reduced; reduced; increased; increased

ADAD, autosomal dominant Alzheimer disease; CSF, cerebrospinal fluid; EOAD, sporadic early-onset (<65 years of age) AD; LOAD, sporadic late-onset AD. a A subset of ADAD manifests spastic paraparesis and behavioural presentations preceding memory decline. About 5% of sporadic cases manifest AD pathology with a non-amnestic presentation, the so-called atypical AD cases. b According to post-mortem studies. c For more details about the neuromodulatory subcortical system, see refs. 85,86. d PET has a low resolution to capture most subcortical structures.